Vascular adverse events in chronic myeloid leukaemia patients during tyrosine kinase inhibitor therapy in daily clinical practice – analysis from the INFINITY database
Transfuze a hematologie dnes · 2023
DOI: 10.48095/cctahd202329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, 2023. Verfasst von Petra Čičátková und 11 weiteren Autor:innen.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Čičátková, P., Žáčková, D., Horňák, T., Klamová, H., Bělohlávková, P., Stejskal, L., Křístková, Z., Baranová, J., Kvetková, A., Semerád, L., Procházková, J., & Mayer, J. (2023). Vascular adverse events in chronic myeloid leukaemia patients during tyrosine kinase inhibitor therapy in daily clinical practice – analysis from the INFINITY database. Transfuze a hematologie dnes. https://doi.org/10.48095/cctahd202329
Vancouver
Čičátková P, Žáčková D, Horňák T, Klamová H, Bělohlávková P, Stejskal L, et al. Vascular adverse events in chronic myeloid leukaemia patients during tyrosine kinase inhibitor therapy in daily clinical practice – analysis from the INFINITY database. Transfuze a hematologie dnes. 2023. doi:10.48095/cctahd202329
BibTeX
@article{itkov2023,
author = {Čičátková, Petra and Žáčková, Daniela and Horňák, Tomáš and Klamová, Hana and Bělohlávková, Petra and Stejskal, Lukáš and Křístková, Zlatuše and Baranová, Jana and Kvetková, Anežka and Semerád, Lukáš and Procházková, Jiřina and Mayer, Jiří},
title = {Vascular adverse events in chronic myeloid leukaemia patients during tyrosine kinase inhibitor therapy in daily clinical practice – analysis from the INFINITY database},
journal = {Transfuze a hematologie dnes},
year = {2023},
doi = {10.48095/cctahd202329}
}
EUVIMED